SSTR2 and neuroendocrine neoplasm: The highest absorbed doses in MPC tumors per administered activity of [67Cu]Cu‐NODAGA-cLAB4‐TATE and [177Lu]Lu‐DOTA-TATE (0.80-0.82 Gy/MBq) are higher compared to other naturally SSTR2-positive neuroendocrine tumor models in mice treated with [177Lu]Lu‐DOTA-TATE, for example NCI‐H69 xenografts (0.33-0.36 Gy/MBq) and GOT‐1 xenografts (0.27 Gy) 51-53.